Successful long-term terbinafine therapy in an asthmatic patient with Aspergillus sensitization and bronchiectasis.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28652961)

Published in Med Mycol Case Rep on April 25, 2017

Authors

Isabel Rodriguez-Goncer1, Rob Niven2,3, David W Denning1,3

Author Affiliations

1: National Aspergillosis Centre, University Hospital of South Manchester, M23 9LT Manchester, UK.
2: Severe Asthma Service, Department of Respiratory Medicine, University Hospital of South Manchester, M23 9LT Manchester, UK.
3: The University of Manchester and Manchester Academic Health Science Centre, Manchester, UK.

Articles cited by this

The link between fungi and severe asthma: a summary of the evidence. Eur Respir J (2006) 3.16

Allergic bronchopulmonary aspergillosis. Chest (2009) 2.54

Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy (2013) 2.03

IgE sensitization to Aspergillus fumigatus is associated with reduced lung function in asthma. Am J Respir Crit Care Med (2010) 1.91

Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization. J Asthma (2012) 1.67

Azole cross-resistance in Aspergillus fumigatus. Antimicrob Agents Chemother (2002) 1.61

Aspergillus sensitization is associated with airflow limitation and bronchiectasis in severe asthma. Allergy (2011) 1.05

Severe asthma with fungal sensitization. Curr Allergy Asthma Rep (2011) 1.04

Itraconazole in chronic cavitary pulmonary aspergillosis: a randomised controlled trial and systematic review of literature. Mycoses (2013) 1.02

Estimation of the burden of chronic and allergic pulmonary aspergillosis in India. PLoS One (2014) 0.98

The effects of antifungal therapy on severe asthma with fungal sensitization and allergic bronchopulmonary aspergillosis. Respirology (2009) 0.94

Isolation of filamentous fungi from sputum in asthma is associated with reduced post-bronchodilator FEV1. Clin Exp Allergy (2012) 0.89

Efficacy and safety of nebulised amphotericin B (NAB) in severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA). J Asthma (2014) 0.81

Fungal sensitisation in severe asthma is associated with the identification of Aspergillus fumigatus in sputum. J Asthma (2016) 0.80

Aerosolized amphotericin for the treatment of allergic bronchopulmonary aspergillosis. Pediatr Pulmonol (2010) 0.80

Randomized, double-blind, comparative study on efficacy and safety of itraconazole pulse therapy and terbinafine pulse therapy on nondermatophyte mold onychomycosis: A study with 90 patients. J Dermatolog Treat (2015) 0.79

Allergic fungal airway disease: pathophysiologic and diagnostic considerations. Curr Opin Pulm Med (2015) 0.79

Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis. Cochrane Database Syst Rev (2016) 0.78